ALGS
Price
$9.87
Change
+$0.66 (+7.17%)
Updated
Dec 3 closing price
Capitalization
60.74M
Intraday BUY SELL Signals
IMRX
Price
$6.75
Change
+$0.06 (+0.90%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
457.8M
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs IMRX

Header iconALGS vs IMRX Comparison
Open Charts ALGS vs IMRXBanner chart's image
Aligos Therapeutics
Price$9.87
Change+$0.66 (+7.17%)
Volume$52.71K
Capitalization60.74M
Immuneering
Price$6.75
Change+$0.06 (+0.90%)
Volume$4.66K
Capitalization457.8M
ALGS vs IMRX Comparison Chart in %
ALGS
Daily Signal:
Gain/Loss:
IMRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALGS vs. IMRX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and IMRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ALGS: $9.31 vs. IMRX: $6.70)
Brand notoriety: ALGS and IMRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 69% vs. IMRX: 29%
Market capitalization -- ALGS: $57.66M vs. IMRX: $457.8M
ALGS [@Biotechnology] is valued at $57.66M. IMRX’s [@Biotechnology] market capitalization is $457.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileIMRX’s FA Score has 0 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • IMRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGS is a better buy in the long-term than IMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while IMRX’s TA Score has 6 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 5 bearish.
  • IMRX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IMRX is a better buy in the short-term than ALGS.

Price Growth

ALGS (@Biotechnology) experienced а -3.62% price change this week, while IMRX (@Biotechnology) price change was -9.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

IMRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRX($458M) has a higher market cap than ALGS($60.7M). IMRX YTD gains are higher at: 204.545 vs. ALGS (-76.632). IMRX has higher annual earnings (EBITDA): -63.7M vs. ALGS (-75.81M). ALGS has more cash in the bank: 123M vs. IMRX (26.4M). IMRX has less debt than ALGS: IMRX (4M) vs ALGS (6.88M). ALGS has higher revenues than IMRX: ALGS (3.17M) vs IMRX (0).
ALGSIMRXALGS / IMRX
Capitalization60.7M458M13%
EBITDA-75.81M-63.7M119%
Gain YTD-76.632204.545-37%
P/E RatioN/AN/A-
Revenue3.17M0-
Total Cash123M26.4M466%
Total Debt6.88M4M172%
TECHNICAL ANALYSIS
Technical Analysis
ALGSIMRX
RSI
ODDS (%)
Bearish Trend 6 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
89%
Momentum
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
86%
MACD
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 6 days ago
89%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
87%
Aroon
ODDS (%)
Bearish Trend 6 days ago
87%
Bullish Trend 6 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signal:
Gain/Loss:
IMRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGACX12.67N/A
N/A
Calvert Global Energy Solutions C
FRIFX12.30N/A
N/A
Fidelity Real Estate Income
MPLIX16.26N/A
N/A
Praxis International Index I
ASILX16.35N/A
N/A
AB Select US Long/Short I
MGKCX13.23N/A
N/A
Morgan Stanley Global Permanence C

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+0.11%
BEAM - ALGS
45%
Loosely correlated
-2.83%
SYRE - ALGS
45%
Loosely correlated
-0.91%
ARWR - ALGS
44%
Loosely correlated
+3.08%
XNCR - ALGS
44%
Loosely correlated
-3.15%
RXRX - ALGS
42%
Loosely correlated
-0.69%
More

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with SPRB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
-5.50%
SPRB - IMRX
52%
Loosely correlated
+8.47%
APVO - IMRX
33%
Poorly correlated
-3.79%
ALGS - IMRX
30%
Poorly correlated
+0.11%
ORMP - IMRX
29%
Poorly correlated
+0.36%
SRRK - IMRX
29%
Poorly correlated
-2.12%
More